VAERS reports by lot

GSK DTaP/Tdap lot H242K: VAERS reports

25 VAERS reports list lot H242K as a GSK DTaP/Tdap vaccine, received between 2023-01-28 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
4%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1935%
Neurological916%
General / Systemic (non-local)916%
Musculoskeletal611%
Gastrointestinal47%
Dermatological (non-injection-site)35%
Allergic / Anaphylactic24%
Cardiac / Cardiovascular12%
Autoimmune / Immune-mediated12%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Massachusetts3
Iowa2
Oregon2
Arizona2
Indiana2
Virginia1
Alabama1
Tennessee1
California1
Georgia1
Michigan1
Colorado1

Reports by month received

2023-011
2023-034
2023-0413
2023-052
2023-061
2023-081
2024-031
2024-062

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.